Your browser doesn't support javascript.
Knowledge, Attitudes, and Practices (KAP) toward the COVID-19 Vaccine in Oman: A Pre-Campaign Cross-Sectional Study.
Al-Marshoudi, Sabria; Al-Balushi, Haleema; Al-Wahaibi, Adil; Al-Khalili, Sulien; Al-Maani, Amal; Al-Farsi, Noura; Al-Jahwari, Adhari; Al-Habsi, Zeyana; Al-Shaibi, Maryam; Al-Msharfi, Mahfoodh; Al-Ismaili, Ahlam; Al-Buloshi, Hood; Al-Rawahi, Bader; Al-Barwani, Khalifa; Al-Abri, Seif.
  • Al-Marshoudi S; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Balushi H; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Wahaibi A; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Khalili S; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Maani A; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Farsi N; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Jahwari A; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Habsi Z; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Shaibi M; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Msharfi M; National Center for Statistic and Information (NCSI), Muscat 133, Oman.
  • Al-Ismaili A; National Center for Statistic and Information (NCSI), Muscat 133, Oman.
  • Al-Buloshi H; National Center for Statistic and Information (NCSI), Muscat 133, Oman.
  • Al-Rawahi B; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
  • Al-Barwani K; National Center for Statistic and Information (NCSI), Muscat 133, Oman.
  • Al-Abri S; Directorate-General for Disease Surveillance and Control (DGDSC), Ministry of Health, Muscat 393, Oman.
Vaccines (Basel) ; 9(6)2021 Jun 04.
Article in English | MEDLINE | ID: covidwho-1259644
ABSTRACT
Oman is globally acknowledged for its well-structured immunization program with high vaccination coverage. The massive spread of misinformation brought on by the COVID-19 pandemic, as well as the easy access to various media channels, may affect acceptance of a vaccine, despite the inherent trust in the local system. This cross-sectional study evaluated the knowledge, attitudes, and practice (KAP) in Oman toward COVID-19 vaccines. It included 3000 randomly selected adults answering a structured questionnaire via telephone. Participants were 66.7% Omani, 76% male, and 83.7% without comorbidities. Their mean age was 38.27 years (SD ± 10.45). Knowledge of COVID-19's symptoms, mode of transmission, and attitudes toward the disease was adequate; 88.4% had heard of the vaccine, 59.3% would advise others to take it, 56.8% would take it themselves, and 47.5% would take a second dose. Males (CI = 2.37, OR = (2.00-2.81)) and Omani (CI = 1.956, OR = (4.595-2.397)) were more willing to be vaccinated. The history of chronic disease, source of vaccine knowledge, and education level were factors that affected the willingness to accept the vaccine. The Omani community's willingness to take the COVID-19 vaccine can be enhanced by utilizing social media and community influencers to spread awareness about the vaccine's safety and efficacy.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9060602

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Experimental Studies / Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Language: English Year: 2021 Document Type: Article Affiliation country: Vaccines9060602